EDGAR Filing Documents for 0001391609-17-000193

Form 8-K - Current report:

SEC Accession No. 0001391609-17-000193

Filing Date

2017-07-27

Accepted

2017-07-27 16:10:25

Documents

Period of Report

2017-06-26

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	f8k_nulf062617.htm	8-K	15543
2	SECURITIES PURCHASE AGREEMENT	ex10_1spa.htm	EX-10.1	79346
3	CONVERTIBLE NOTE	ex10_2convertiblenote.htm	EX-10.2	82700
	Complete submission text file	0001391609-17-000193.txt		178968

Mailing Address 1031 CALLE RECODO, SUITE B SAN CLEMENTE CA 92673

Business Address 1031 CALLE RECODO, SUITE B SAN CLEMENTE CA 92673 949-973-0684

NuLife Sciences, Inc. (Filer) CIK: 0001592603 (see all company filings)